Skip to content

Rebound Pain and Related Factors in Postoperative Patients With Total Knee Arthroplasty

Rebound Pain and Related Factors in Patients Who Underwent Femoral Nerve Block for Postoperative Pain Control in Total Knee Arthroplasty

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05910281
Enrollment
150
Registered
2023-06-18
Start date
2023-07-01
Completion date
2025-12-01
Last updated
2023-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications, Postoperative Nausea and Vomiting, Postoperative Pain

Brief summary

The aim of this prospective observational study is to detect rebound pain and related factors in postoperative patients with total knee arthroplasty.

Detailed description

Total knee arthroplasty is an effective treatment method for knee osteoarthritis and because it is an invasive method, more than 50% of patients experience postoperative pain. Peripheral nerve blocks are widely used for optimal pain control. The femoral block is a frequently preferred peripheral nerve block method for postoperative analgesia in total knee arthroplasty surgery. However, after peripheral nerve block, a condition called rebound pain (rebound pain), which is described as very severe pain, lasting about 2 hours, usually of the burning type, occurs. The aim of this prospective observational study is to detect rebound pain and related factors in postoperative patients with total knee arthroplasty.

Interventions

None listed

Sponsors

Gulhane Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years older age who underwent total knee arthroplasty

Exclusion criteria

* ASA score 4 or \>4 * Active infection * End stage organ failure * Pregnancy * Established diagnosis neuropsychiatric disease ( epilepsy, neuropathy, neuromuscular disease, cerebrovascular disease...) * Uses of oral corticosteroids

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scalepostoperative 3-5 days fellow-upThe VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

Countries

Turkey (Türkiye)

Contacts

Primary ContactBilal Katipoglu
drbilal07@gmail.com+905543330380

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026